| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.33(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,422 |
| 52
Week Range: |
$6.13 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,455 |
163,534 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,144 |
247,906 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,161 |
219,762 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,518 |
446,137 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,324 |
395,619 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,320 |
123,099 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,637 |
105,779 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
32,626 |
210,601 |
|
- |
|
| Spurr Robert |
President, Salix |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,892 |
59,336 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
36,250 |
155,079 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
63,439 |
346,295 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,298 |
89,611 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,892 |
100,142 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
74,150 |
845,823 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$54,639 |
D/D |
(1,739) |
79,313 |
|
- |
|
| Spurr Robert |
President, Salix |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$102,178 |
D/D |
(3,252) |
35,444 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$885,793 |
D/D |
(28,192) |
771,673 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$170,799 |
D/D |
(5,436) |
177,975 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$104,094 |
D/D |
(3,313) |
76,250 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$168,631 |
D/D |
(5,367) |
118,829 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-01 |
4 |
D |
$31.42 |
$495,022 |
D/D |
(15,755) |
282,856 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2020-12-31 |
4 |
A |
$20.80 |
$6,864 |
D/D |
330 |
101,501 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-12-15 |
4 |
D |
$20.61 |
$66,447 |
D/D |
(3,224) |
183,411 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-12-04 |
4 |
S |
$19.87 |
$2,266,398 |
D/D |
(114,055) |
235,035 |
|
-51% |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-12-04 |
4 |
OE |
$14.38 |
$1,640,111 |
D/D |
114,055 |
349,090 |
|
- |
|
1058 Records found
|
|
Page 10 of 43 |
|
|
0.27 (4.29%) 
